These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5299836)

  • 1. Brain barrier to 5-HTP.
    Glassman A
    N Engl J Med; 1968 Feb; 278(5):281. PubMed ID: 5299836
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain barrier to 5-HTP.
    Engelman K; Lovenberg W; Sjoerdsma A
    N Engl J Med; 1968 Feb; 278(5):281. PubMed ID: 5299837
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of ethanol on the in vivo conversion of 5-HTP-14C to serotonin-14C, 5-hydroxyindoleacetaldehyde-14C and its metabolites in rat brain.
    Feldstein A; Sidel CM
    Int J Neuropharmacol; 1969 Jul; 8(4):347-51. PubMed ID: 5307042
    [No Abstract]   [Full Text] [Related]  

  • 4. 5-Hydroxytryptophan (5-HTP) uptake and decarboxylation in the kitten brain.
    Kitahama K; Jouvet A; Fujimiya M; Nagatsu I; Arai R
    J Neural Transm (Vienna); 2002 May; 109(5-6):683-9. PubMed ID: 12111460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative penetration of L-dopa and 5-HTP through the brain barrier using dimethyl sulfoxide.
    De la Torre JC
    Experientia; 1970 Oct; 26(10):1117-8. PubMed ID: 5312418
    [No Abstract]   [Full Text] [Related]  

  • 6. Impaired permeability of the blood-cerebrospinal fluid barrier in hyperphenylalaninaemia.
    Piel N; Lane JD; Hüther G; Neuhoff V
    Neuropediatrics; 1982 May; 13(2):88-92. PubMed ID: 6982428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of monoamine oxidase inhibitors on 5-hydroxytryptamine synthesis in the brain.
    Weber LJ
    Proc Soc Exp Biol Med; 1966 Oct; 123(1):35-8. PubMed ID: 4380811
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biosynthesis and metabolism of indolamines in the pineal organ of Lacerta (reptiles, larcertilians). II. Monoamine oxidase activity and incorporation of 3H-5-HTP and 3H-5-HT under normal and experimental conditions].
    Collin JP; Meiniel A
    Z Zellforsch Mikrosk Anat; 1973 Dec; 145(3):331-61. PubMed ID: 4543951
    [No Abstract]   [Full Text] [Related]  

  • 9. Low brain uptake of L-[11C]5-hydroxytryptophan in major depression: a positron emission tomography study on patients and healthy volunteers.
    Agren H; Reibring L; Hartvig P; Tedroff J; Bjurling P; Hörnfeldt K; Andersson Y; Lundqvist H; Långström B
    Acta Psychiatr Scand; 1991 Jun; 83(6):449-55. PubMed ID: 1882697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of L-DOPA and 5-HTP in the exocrine pancreas studied with autoradiography in the electron microscope.
    Alm P; Ekholm R; Ericson LE
    J Ultrastruct Res; 1972 Feb; 38(3):265-78. PubMed ID: 4536738
    [No Abstract]   [Full Text] [Related]  

  • 11. Feedback control of rat brain 5-hydroxytryptamine synthesis.
    Macon JB; Sokoloff L; Glowinski J
    J Neurochem; 1971 Mar; 18(3):323-31. PubMed ID: 5314774
    [No Abstract]   [Full Text] [Related]  

  • 12. Replenishment by 5-hydroxytryptophan of the amine stores in the central 5-hydroxytryptamine neurons after depletion induced by reserpine or by an inhibitor of monoamine synthesis.
    Corrodi H; Fuxe K; Hökfelt T
    J Pharm Pharmacol; 1967 Jul; 19(7):433-8. PubMed ID: 4382634
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-HTP hypothesis of schizophrenia.
    Fukuda K
    Med Hypotheses; 2014 Jan; 82(1):20-3. PubMed ID: 24280562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FURTHER STUDIES ON: ONE DAY TREATMENT OF DEPRESSION WITH 5-HTP.
    KLINE NS; SACKS W; SIMPSON GM
    Am J Psychiatry; 1964 Oct; 121():379-81. PubMed ID: 14211415
    [No Abstract]   [Full Text] [Related]  

  • 15. Relief of depression within one day using an M.A.O. inhibitor and intravenous 5-HTP.
    KLINE NS; SACKS W
    Am J Psychiatry; 1963 Sep; 120():274-5. PubMed ID: 14033525
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of carbidopa on the cerebral accumulation of exogenous L-5-hydroxytryptophan in mice.
    Magnussen I
    Acta Pharmacol Toxicol (Copenh); 1984 Sep; 55(3):199-202. PubMed ID: 6334429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FUNCTION OF N-ACETYL ASPARTIC ACID IN THE BRAIN: EFFECTS OF CERTAIN DRUGS.
    MCINTOSH JC; COOPER JR
    Nature; 1964 Aug; 203():658. PubMed ID: 14250993
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of oral 5-HTP administration on 5-HTP and 5-HT immunoreactivity in monoaminergic brain regions of rats.
    Lynn-Bullock CP; Welshhans K; Pallas SL; Katz PS
    J Chem Neuroanat; 2004 May; 27(2):129-38. PubMed ID: 15121217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmented brain 5-HT crosses the blood-brain barrier through the 5-HT transporter in rat.
    Nakatani Y; Sato-Suzuki I; Tsujino N; Nakasato A; Seki Y; Fumoto M; Arita H
    Eur J Neurosci; 2008 May; 27(9):2466-72. PubMed ID: 18445233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase inhibitory properties of milacemide in rats.
    Truong DD; Diamond B; Pezzoli G; Mena MA; Fahn S
    Life Sci; 1989; 44(15):1059-66. PubMed ID: 2784529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.